Advanced search
Publication Cover
Cancer Biology & Therapy Volume 22, 2021 - Issue 4
Submit an article Journal homepage
1,078
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway

Xiao-Lin Wanga Department of Thoracic Surgery, Northern Jiangsu People’s Hospital and Clinical Medical College of Yangzhou University, Yangzhou, P. R. ChinaView further author information
,
Shi-Chun Lua Department of Thoracic Surgery, Northern Jiangsu People’s Hospital and Clinical Medical College of Yangzhou University, Yangzhou, P. R. ChinaView further author information
,
Chao Suna Department of Thoracic Surgery, Northern Jiangsu People’s Hospital and Clinical Medical College of Yangzhou University, Yangzhou, P. R. ChinaView further author information
,
Wei-Guo Jina Department of Thoracic Surgery, Northern Jiangsu People’s Hospital and Clinical Medical College of Yangzhou University, Yangzhou, P. R. ChinaView further author information
,
Yi-Wei Fana Department of Thoracic Surgery, Northern Jiangsu People’s Hospital and Clinical Medical College of Yangzhou University, Yangzhou, P. R. ChinaView further author information
,
Yu-Sheng Shua Department of Thoracic Surgery, Northern Jiangsu People’s Hospital and Clinical Medical College of Yangzhou University, Yangzhou, P. R. ChinaCorrespondence[email protected]
View further author information
,
Hong-Can Shia Department of Thoracic Surgery, Northern Jiangsu People’s Hospital and Clinical Medical College of Yangzhou University, Yangzhou, P. R. ChinaCorrespondence[email protected]
View further author information
&
Ling-Feng Minb Department of Respiratory Medicine, Northern Jiangsu People’s Hospital and Clinical Medical College of Yangzhou University, Yangzhou, P. R. ChinaCorrespondence[email protected]
View further author information
 show all
Pages 324-332 | Received 20 Jun 2019, Accepted 10 Mar 2021, Published online: 10 May 2021

References

  • Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387. doi:10.1016/j.ejca.2018.07.005.
  • Cho WC, Yip TT, Cheng WW, Au JS. Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis. Br J Cancer. 2010;102(12):1731–1735. doi:10.1038/sj.bjc.6605700.
  • Li XF, Ma Y. Preclinical visualization of hypoxia, proliferation and glucose metabolism in non-small cell lung cancer and its metastasis. Boston (MA): Springer; 2014.
  • Giatromanolaki A, Sivridis E, Arelaki S, Koukourakis MI. Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis. Exp Lung Res. 2017;43(4–5):167–174. doi:10.1080/01902148.2017.1328714.
  • Sanchez JG, Okreglicka K, Chandrasekaran V, Welker JM, Sundquist WI, Pornillos O. The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proc Natl Acad Sci U S A. 2014;111(7):2494–2499. doi:10.1073/pnas.1318962111.
  • Wang X, Shi W, Shi H, Lu S, Wang K, Sun C, He J, Jin W, Lv X, Zou H, et al. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells. J Exp Clin Cancer Res. 2016;35(1):100. doi:10.1186/s13046-016-0379-y.
  • Ahmad MK, Abdollah NA, Shafie NH, Yusof NM, Razak SRA. Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer. Cancer Biol Med. 2018;15:14–28. doi:10.20892/j.2095-3941.2017.0107.
  • Okudela K, Yazawa T, Woo T, Sakaeda M, Ishii J, Mitsui H, Shimoyamada H, Sato H, Tajiri M, Ogawa N, et al. Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am J Pathol. 2009;175(2):867–881. doi:10.2353/ajpath.2009.080489.
  • Furukawa T, Sunamura M, Motoi F, Matsuno S, Horii A. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am J Pathol. 2003;162(6):1807–1815. doi:10.1016/S0002-9440(10)64315-5.
  • Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-beta1/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer. 2015;15(1):97. doi:10.1186/s12885-015-1119-y.
  • Sun H, Zhu A, Zhang L, Zhang J, Zhong Z, Wang F. Knockdown of PKM2 suppresses tumor growth and invasion in lung adenocarcinoma. Int J Mol Sci. 2015;16(10):24574–24587. doi:10.3390/ijms161024574.
  • Liu Y, He C, Huang X. Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism. Oncotarget. 2017;8(43):75206–75216. doi:10.18632/oncotarget.20663.
  • Jing HZ, Qiu F, Chen SZ, Su L, Qu C. Tripartite-motif protein 25 and pyruvate kinase M2 protein expression in non-small cell lung cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35:437–441.
  • Vicent S, Lopez-Picazo JM, Toledo G, Lozano MD, Torre W, Garcia-Corchon C, Quero C, Soria JC, Martin-Algarra S, Manzano RG, et al. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br J Cancer. 2004;90(5):1047–1052. doi:10.1038/sj.bjc.6601644.
  • Wang J, Huang S. Fisetin inhibits the growth and migration in the A549 human lung cancer cell line via the ERK1/2 pathway. Exp Ther Med. 2018;15(3):2667–2673. doi:10.3892/etm.2017.5666.
  • Zhang Z, Kobayashi S, Borczuk AC, Leidner RS, Laframboise T, Levine AD, Halmos B. Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells. Carcinogenesis. 2010;31(4):577–586. doi:10.1093/carcin/bgq020.
  • Xie XL, Nie X, Wu J, Zhang F, Zhao LL, Lin YL, Yin YJ, Liu H, Shu YN, Miao SB, et al. Smooth muscle 22alpha facilitates angiotensin II-induced signaling and vascular contraction. J Mol Med (Berl). 2015;93(5):547–558. doi:10.1007/s00109-014-1240-4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.